Literature DB >> 24788010

Comment on, 'Factors affecting outcomes of corneal collagen crosslinking treatment'.

P Vinciguerra1, V Romano2, M R Romano3, C Azzolini4, R Vinciguerra5.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24788010      PMCID： PMC4135268          DOI： 10.1038/eye.2014.88

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Stromal opacity after cross-linking.

Authors:  Paolo Vinciguerra; Elena Albè; Mario R Romano; Laura Sabato; Silvia Trazza
Journal:  J Refract Surg       Date:  2012-03       Impact factor: 3.573

2.  Modulation of central corneal thickness by various riboflavin eyedrop compositions in porcine corneas.

Authors:  Jan M Vetter; Stephan Brueckner; Marija Tubic-Grozdanis; Urs Vossmerbäumer; Norbert Pfeiffer; Sabine Kurz
Journal:  J Cataract Refract Surg       Date:  2012-01-20       Impact factor: 3.351

3.  Corneal cross-linking as a treatment for keratoconus: four-year morphologic and clinical outcomes with respect to patient age.

Authors:  Riccardo Vinciguerra; Mario R Romano; Fabrizio I Camesasca; Claudio Azzolini; Silvia Trazza; Emanuela Morenghi; Paolo Vinciguerra
Journal:  Ophthalmology       Date:  2013-01-03       Impact factor: 12.079

4.  Characteristics influencing outcomes of corneal collagen crosslinking for keratoconus and ectasia: implications for patient selection.

Authors:  Steven A Greenstein; Peter S Hersh
Journal:  J Cataract Refract Surg       Date:  2013-08       Impact factor: 3.351

5.  Factors affecting outcomes of corneal collagen crosslinking treatment.

Authors:  I Toprak; V Yaylalı; C Yildirim
Journal:  Eye (Lond)       Date:  2013-10-18       Impact factor: 3.775
  5 in total
  1 in total

1.  Response to Vinciguerra et al.

Authors:  I Toprak; V Yaylalı; C Yildirim
Journal:  Eye (Lond)       Date:  2014-05-02       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.